Clinical Trial Update: Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy regimens with or without cetuximab in stage III colon cancer patients after surgery; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Colon Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Stage III Colon Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-02-09